JP2024547029A5 - - Google Patents
Info
- Publication number
- JP2024547029A5 JP2024547029A5 JP2024536410A JP2024536410A JP2024547029A5 JP 2024547029 A5 JP2024547029 A5 JP 2024547029A5 JP 2024536410 A JP2024536410 A JP 2024536410A JP 2024536410 A JP2024536410 A JP 2024536410A JP 2024547029 A5 JP2024547029 A5 JP 2024547029A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- composition
- pain
- sequence
- day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306835.6 | 2021-12-17 | ||
| EP21306835 | 2021-12-17 | ||
| PCT/EP2022/086559 WO2023111348A1 (en) | 2021-12-17 | 2022-12-19 | Peptides and methods for use in treating pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024547029A JP2024547029A (ja) | 2024-12-26 |
| JP2024547029A5 true JP2024547029A5 (cg-RX-API-DMAC7.html) | 2026-01-06 |
Family
ID=79317102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024536410A Pending JP2024547029A (ja) | 2021-12-17 | 2022-12-19 | 疼痛の処置における使用のためのペプチド及び方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250051395A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4447991A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024547029A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240126864A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118401249A (cg-RX-API-DMAC7.html) |
| AR (1) | AR129864A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022413983A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3239578A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL313183A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024007301A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202344689A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023111348A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026119985A1 (en) * | 2024-12-03 | 2026-06-11 | Tafalgie Therapeutics | Peptides for use in treating wounds and inflammatory diseases |
| WO2026119983A1 (en) * | 2024-12-03 | 2026-06-11 | Tafalgie Therapeutics | Peptides for use in treating pain, wounds and inflammatory diseases |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11514853A (ja) | 1995-09-08 | 1999-12-21 | ジエンザイム コーポレイション | 遺伝子治療のための改良されたaavベクター |
| CN103589692B (zh) | 2001-11-13 | 2018-07-24 | 宾夕法尼亚大学托管会 | 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法 |
| WO2006013462A2 (en) * | 2004-07-30 | 2006-02-09 | Nsgene A/S | Growth factors nsg28, nsg30, and nsg32 |
| EP2801369A1 (en) | 2013-05-06 | 2014-11-12 | Centre National De La Recherche Scientifique | TAFA4 compounds and uses thereof for treating pain |
| CN108699604A (zh) | 2016-03-08 | 2018-10-23 | 艾克斯-马赛大学 | 用于预测急性疼痛转变为慢性疼痛的myo1a以及myo1a用于治疗疼痛的用途 |
-
2022
- 2022-12-19 CA CA3239578A patent/CA3239578A1/en active Pending
- 2022-12-19 MX MX2024007301A patent/MX2024007301A/es unknown
- 2022-12-19 US US18/719,934 patent/US20250051395A1/en active Pending
- 2022-12-19 AR ARP220103509A patent/AR129864A1/es unknown
- 2022-12-19 IL IL313183A patent/IL313183A/en unknown
- 2022-12-19 WO PCT/EP2022/086559 patent/WO2023111348A1/en not_active Ceased
- 2022-12-19 JP JP2024536410A patent/JP2024547029A/ja active Pending
- 2022-12-19 AU AU2022413983A patent/AU2022413983A1/en active Pending
- 2022-12-19 CN CN202280083300.3A patent/CN118401249A/zh active Pending
- 2022-12-19 KR KR1020247023481A patent/KR20240126864A/ko active Pending
- 2022-12-19 TW TW111148815A patent/TW202344689A/zh unknown
- 2022-12-19 EP EP22840601.3A patent/EP4447991A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101999756B1 (ko) | Cd36 발현을 감소시키는 방법 | |
| AU2011218009B2 (en) | Treatments for gastrointestinal disorders | |
| US11672841B2 (en) | Methods for treating heart disease in a subject with Friedreich's ataxia by an aromatic-cationic peptide | |
| JP4335910B2 (ja) | メタスチン誘導体およびその使用 | |
| JP2019052157A (ja) | 左室リモデリングの予防または治療のための方法 | |
| JP6069663B2 (ja) | 抗炎症医薬製品 | |
| EP3066077A1 (en) | Treatment of cardiac remodeling and other heart conditions | |
| US10624944B2 (en) | Anti-inflammatory peptides for treating non-alcoholic steatohepatitis (NASH) | |
| US20190022167A1 (en) | Methods and compositions for the prevention and treatment of duchenne muscular dystrophy | |
| AU710303B2 (en) | Use of insulin-like growth factors (I) and (II) for inhibition of inflammatory response | |
| JP2025519127A5 (cg-RX-API-DMAC7.html) | ||
| CN111417647A (zh) | 新型senolytic肽 | |
| JP4933440B2 (ja) | 経皮デリバリーのための薬剤組成物 | |
| KR102555817B1 (ko) | 당뇨병 및 관련 질환의 치료 및 예방을 위한 펩타이드 | |
| US8895503B2 (en) | Pharmaceutical composition for transnasal administration of peptide hormones or cytokines | |
| EP4419130B1 (en) | Il-4 derived peptides for use in the treatment of obesity | |
| TW201302214A (zh) | 治療或預防皮膚癌之類鋅手指胜肽、其表現質體、及包含其之醫藥組成物 | |
| EP3536382A1 (en) | Prophylactic or therapeutic agent for inflammatory skin disease | |
| JP2023544910A (ja) | コロナウイルス治療法 | |
| US20240350578A1 (en) | Functional outcomes after spinal cord injury | |
| KR102829639B1 (ko) | c-Met의 에피토프를 포함하는 암 백신 및 이의 용도 | |
| WO2013131879A1 (en) | New application for pasireotide | |
| WO2025129029A2 (en) | Combinations of foralumab with glucagon-like peptide 1 (glp-1) agonists or sodium-glucose cotransporter-2 (sglt2) inhibitors and methods of use thereof | |
| TW202528339A (zh) | 用於治療或預防肝臟病症之骨髓源性生長因子 | |
| HK1212718B (en) | Methods for reducing cd36 expression |